Heart DiseaseIntroForumsNewsAnatomy & PhysiologyLaboratory
Search

Heart DiseaseIntroForumsNewsAnatomy & PhysiologyHeartzineFish Oil Capsules Cut Death Risk for Heart PatientsKids with Fatty Liver Face Increased Heart RiskLow Fat Milk Can Cut Heart Disease RiskChinese Rice Derivative Good for Heart HealthLaboratory Letters to the Editor
 
 

In the Forum

New Drug Combination, Better for Blood Pressure

      Volume: 12 (05/09/2005)
Major new research suggests that a combination of modern drugs is better at lowering blood pressure than the one traditionally prescribed, and also more effective at reducing risk of heart disease and stroke.

The findings of the study led by Dr. Bjorn Dahlof of Sahlgrenska University Hospital in Goteborg, Sweden were presented at the annual conference of the European Society of Cardiology. They prompted debate because they contradict an earlier study, and there were experts who sustain the idea that the newer pills may have proved more effective because they have few side effects as compared to the older ones and might have been taken on a more regular basis by patients.

ADVERTISEMENT

19,257 patients with high blood pressure were included in the study, of which approximately half were treated with the older combination - a beta-blocker called atenolol, to slow the heart rate and a diuretic, to reduce fluid in the body, and the other half received the modern treatment, made of a calcium blocker called amlodopine (to slow the heart rate) and an ACE inhibitor called perindopril, which has the role of lowering blood pressure by relaxing the vessels.

After 5 years, the results indicated a blood pressure level that was 2.7 points lower in people taking the newer medication, as compared to those treated traditionally. Also, the incidence of strokes was 23% lower, of heart-related deaths, 24% lower and there were 30% fewer new diagnosis of diabetes. As for complications, there was no difference between the two groups.

The study stopped prematurely when it reached these results, because it was considered unethical to continue, given such a big difference between the two groups.

Other problems raised at the conference included whether heart attacks, strokes and deaths were lowered because of the lowered blood pressure, or due to other benefits the drug combination has that are yet to be discovered.

The study was mainly funded by Pfizer, manufacturer of the new calcium blocker.

Related Discussions

Measurement of Blood Pressure
A new way to keep blood pressure under control
Blood pressure disorders

Related Articles

Drug Combination Doesn’t Lower Heart Attack Risk
Measurement of Blood Pressure
A Novel Way to Control Blood Pressure
Signup to the Newsletter
 
Enter your email:
Download as PDF
 
PDF Version
For Printing or Archiving
Add to Bookmarks
 
Add Bookmark

ADVERTISEMENT



 Copyright © Alloyfish Ltd. 2005-6. This site does not provide any medical advice. Do not make medical decisions without a doctor.